Efficacy and safety of camrelizumab combined with chemotherapy (irinotecan combined with platinum) followed by camrelizumab combined with apatinib in the first-line treatment of advanced small cell lung cancer: A phase II study.

被引：0
|
作者：
Ni, Jun
Zhang, Xiaotong
Pan, Ruili
Wang, Hanping
Si, Xiaoyan
Cui, Xiaoxia
Zhang, Li
机构：
[1] Chinese Acad Med Sci Peking Union Med Coll, Peking Union Med Hosp, Dept Pulm & Crit Care Med, Beijing, Peoples R China
[2] Peking Union Med Coll & Chinese Acad Med Sci, Dept Pulm & Crit Care Med, Peking Union Med Coll Hosp, Beijing, Peoples R China
[3] Chinese Acad Med Sci, Dept Resp Med, Peking Union Med Coll Hosp, Beijing, Peoples R China
[4] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Beijing, Peoples R China
[5] Peking Union Med Coll & Chinese Acad Med Sci, Dept Pulm & Crit Care Med, Peking Union Med Coll Hosp, Beijing, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8573
引用
收藏
页数：1
相关论文
共 50 条
  • [21] An exploratory clinical study of β-glucan combined with camrelizumab and SOX chemotherapy as first-line treatment for advanced gastric adenocarcinoma
    Chu, Yunqian
    He, Xuan
    Xue, Ya
    Jiang, Hua
    Zhu, Chan
    Qi, Chunjian
    Zhang, Xing
    Chen, Dongsheng
    Dai, Hanjue
    Xian, Qingying
    Zhu, Wenyu
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [22] Efficacy and safety of second-line camrelizumab combined with apatinib and chemotherapy in patients with advanced lung adenocarcinoma: A prospective, open-label, multicentric study
    Yao, Yiwei
    Wang, Yong
    Du, Yingying
    Jiang, Fengshou
    Liang, Hui
    Bi, Minghong
    Xie, Hua
    Peng, Wanren
    Pan, Yueyin
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 125
  • [23] Clinical study on the second-line treatment of advanced esophageal squamous cell carcinoma with camrelizumab combined with apatinib and irinotecan: A single-arm, multicenter, phase II study
    He, Yifu
    Li, Chenghui
    Zhang, Fenglin
    Hu, Bing
    Sun, Yubei
    Xia, Xiaoyang
    Zhang, Yanshun
    Wang, Gang
    Xu, Tengyun
    Duan, Aixiong
    Wu, Shusheng
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [24] Efficacy and safety of camrelizumab and apatinib combined with neoadjuvant concurrent chemoradiation for MSS locally advanced rectal cancer
    Jiang, Tao
    Wang, Dongsheng
    Cheng, Jingjing
    Wei, Xiaojuan
    Fu, Jialei
    Cao, Lianjing
    Lei, Peijie
    Zhang, Xianxiang
    Gao, Yuan
    Hu, Jilin
    Zhang, Hongjun
    Cao, Bin
    He, Baoguo
    Mao, Qingdong
    Qi, Peng
    Wang, Jigang
    Zhou, Xiaoming
    Tan, Junying
    Lu, Haijun
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [25] Efficacy and safety of camrelizumab combined with apatinib in advanced triple-negative breast cancer: an open-label phase II trial
    Liu, Jieqiong
    Liu, Qiang
    Li, Ying
    Li, Qian
    Su, Fengxi
    Yao, Herui
    Su, Shicheng
    Wang, Quanren
    Jin, Liang
    Wang, Ying
    Lau, Wan Yee
    Jiang, Zefei
    Song, Erwei
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (01)
  • [26] A Phase II Clinical Study Evaluating Camrelizumab Combined With Apatinib and Albumin Paclitaxel for Advanced Non-Small CellLung Cancer
    Wu, L.
    Pu, X.
    Chen, B.
    Xu, F.
    Li, J.
    Li, K.
    Xu, L.
    Wang, Q.
    Kong, Y.
    Liu, L.
    Xu, Y.
    Xiao, M.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1016 - S1016
  • [27] Updated efficacy and safety results from the phase Ib/II study of surufatinib combined with camrelizumab and chemotherapy in patients with advanced colorectal cancer
    Li, Sheng
    Zhu, Liangjun
    Li, Xiaoyou
    Huang, Jiayuan
    Bao, Jun
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [28] Efficacy and safety of camrelizumab plus apatinib as second-line treatment for advanced squamous non-small cell lung cancer
    Gao, Guanghui
    Zhao, Jun
    Ren, Shengxiang
    Wang, Yina
    Chen, Gongyan
    Chen, Jianhua
    Gu, Kangsheng
    Guo, Renhua
    Pan, Yueyin
    Wang, Quanren
    Li, Weixia
    Yang, Xinfeng
    Zhou, Caicun
    ANNALS OF TRANSLATIONAL MEDICINE, 2022, 10 (08)
  • [29] Apatinib combined with irinotecan in the treatment of small cell lung cancer: A phase II, single-arm, prospective study
    Zhao, Y.
    Guo, L.
    Pu, H.
    Bai, S.
    Yang, M.
    Wang, Y.
    ANNALS OF ONCOLOGY, 2020, 31 : S1043 - S1043
  • [30] Phase Ib trial of camrelizumab combined with chemotherapy and apatinib for neoadjuvant treatment of locally advanced thoracic esophageal squamous cell carcinoma
    Wang, Zhen
    Chen, Xiankai
    Li, Yong
    Qin, Jianjun
    Fang, Yuan
    Yang, Zhaoyang
    Fang, Yan
    Qu, Dong
    Zhang, Ruixiang
    Zheng, Qingfeng
    Kang, Xiaozheng
    Xue, Liyan
    Huang, Jing
    Li, Yin
    He, Jie
    JOURNAL OF THE NATIONAL CANCER CENTER, 2022, 2 (02): : 98 - 105
12345